发明名称 |
PHARMACEUTICAL COMPOSITION FOR TREATING OR AMELIORATING TOXICITIES OR SIDE EFFECTS INDUCED BY MOLECULAR TARGETED THERAPY |
摘要 |
<p>A method for treating or ameliorating mucocutaneous or ocular toxicities or side effects resulting from molecular targeted therapy, including administering to a subject in need thereof a pharmaceutical composition which contains a therapeutically effective amount of a histone deacetylase (HDAC) inhibitor, wherein the mucocutaneous or ocular toxicities or side effects result from molecular targeted therapy.</p> |
申请公布号 |
KR20140041956(A) |
申请公布日期 |
2014.04.04 |
申请号 |
KR20147007209 |
申请日期 |
2009.06.26 |
申请人 |
ASAN LABORATORIES CO., LTD. |
发明人 |
PUI NAM MEW;CHUNG YIH LIN |
分类号 |
A61K31/19;A61K31/165;A61K48/00;A61P17/00 |
主分类号 |
A61K31/19 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|